JAGX Earnings

Quarterly EPS
$-12547.50
Q3 2024
$0.00
Q4 2024
$-8766.75
Q1 2025
$-5384.10
Q2 2025
$-2997.27
Q3 2025
$-2022.19
Q4 2025
$-204.00
Q1 2026
$-235.50
Q2 2026
Latest Revenue1.2M
Latest Net Income-12802000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$235.501.2M-12802000-58.9%+95.6%
Q1 2026-$204.0020.3M8.7M+815.6%+97.7%
Q4 2025-$2,022.193.2M-23193000-7.8%—
Q3 2025-$2,997.273.1M-9648000-0.8%+76.1%
Q2 2025-$5,384.103.0M-10560000+9.5%-324.1%
Q1 2025-$8,766.752.2M-10596000-5.8%+78.9%
Q4 2024—3.5M-10234000+52.6%—
Q3 2024-$12,547.503.1M-10021000+10.5%+95.3%
Q2 2024-$1,269.552.7M-9628000——
Q1 2024-$41,580.002.4M-9368000——
Q4 2023-$133,853.012.3M-9309000——
Q3 2023-$268,465.912.8M-7904000——
Jaguar Health (JAGX) — Earnings